Hubei Goto Biopharm: Notice Regarding the Holding of the Second Extraordinary Shareholders' Meeting in 2024.
Hubei Goto Biopharm: Announcement regarding the wholly-owned subsidiary's plan to apply for a comprehensive credit limit from banks and the company providing guarantee for it.
Hubei Goto Biopharm: Announcement of Resolution of the 25th Meeting of the Second Board of Directors.
Hubei Goto Biopharm: Announcement regarding cumulative new loans exceeding 20% of net assets at the end of the previous year.
Hubei Goto Biopharm: Announcement on the conversion of convertible corporate bonds to stocks in Q2 2024.
Hubei Goto Biopharm: Announcement on the Progress of Providing Guarantees for Applying for Comprehensive Credit Lines for Subsidiaries.
Hubei Goto Biopharm: Hubei Jointown Pharmaceutical Group Co., Ltd.'s Main and Convertible Bonds 2024 Tracking Rating Report.
Hubei Goto Biopharm: Legal Opinion of Beijing Zhonglun (Wuhan) Law Firm on the 2024 First Temporary Shareholders' Meeting of Hubei Jointown Pharmaceutical Co., Ltd.
Hubei Goto Biopharm: Announcement of the resolution of the first extraordinary Shareholders' Meeting in 2024.
Hubei Goto Biopharm: CSI Enterprise Bond Index issued convertible corporate bonds to unspecified entities in Hubei and entrusted management affairs report (2023).
Hubei Goto Biopharm: Announcement regarding the adjustment of the conversion price for convertible bonds into shares.
Hubei Goto Biopharm: Announcement of the implementation of equity distribution in 2023.
Hubei Goto Biopharm: Notice on holding the 2024 First Extraordinary General Meeting of Shareholders
Hubei Goto Biopharm: Announcement of Resolutions of the 24th Meeting of the 2nd Board of Directors
Hubei Goto Biopharm: Announcement on the wholly-owned subsidiary's intention to apply for a comprehensive credit line from the bank and the company will provide a guarantee for it
Hubei Goto Biopharm: Announcement on shareholders and directors holding 5% or more of the company's shares reduced their holdings by 1% and the completion of the supervisors' holdings reduction plan
Hubei Goto Biopharm: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Hubei Goto Biopharm: Legal Opinion of Beijing Zhonglun (Wuhan) Law Firm on the 2023 Annual General Meeting of Shareholders of Hubei Joint Pharmaceutical Co., Ltd.
Hubei Goto Biopharm: CITIC Securities Co., Ltd. report on the 2023 continuous supervision and regular on-site inspection report of Hubei Kyodo Pharmaceutical Co., Ltd.
Hubei Goto Biopharm: CITIC Securities Co., Ltd.'s 2023 follow-up report on Hubei Kyodo Pharmaceutical Co., Ltd.
No Data